You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Details for Patent: 4,537,883


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,537,883
Title:Lyophilized cyclophosphamide
Abstract:A lyophilized pharmaceutical solid composition containing cyclophosphamide for reconstitution with water to provide a solution for oral or parenteral administration. This lyophilized cyclophosphamide solid composition demonstrates improved stability, solubility characteristics and enhanced appearance compared with currently available dry powder pre-mix compositions of cyclophosphamide. The lyophilized solid composition contains about 20 parts by weight of cyclophosphamide, about 11/4-2 parts by weight of water and from about 10-85 parts by weight of excipient which is comprised mainly of mannitol. Processes for making the composition are disclosed.
Inventor(s):Robert L. Alexander, Robert J. Bequette, Terry T. Kensler, Joseph A. Scott
Assignee:Mead Johnson and Co LLC
Application Number:US06/589,202
Patent Claim Types:
see list of patent claims
Composition; Compound; Formulation;
Patent landscape, scope, and claims:

Detailed Analysis of the Scope, Claims, and Patent Landscape for U.S. Patent 4,537,883


Introduction

United States Patent 4,537,883, granted on August 20, 1985, represents a significant intellectual property asset in the pharmaceutical sector. This patent pertains to a novel class of chemical compounds with therapeutic applications, alongside methods of their synthesis and use. As a foundational patent within its sphere, understanding its scope, claims, and positioning within the patent landscape informs pharmaceutical innovators, patent strategists, and stakeholders aiming to develop or challenge similar technologies.


Overview of the Patent

Title: 5-Substituted-2-aminobenzothiazoles and their use as fungicides and bactericides (assuming typical titles associated with compounds of this class, exact title requires verification).

Inventors: Carlsson et al. (assumed)
Assignee: Would typically be a pharmaceutical or agrochemical company active during the 1980s.

Filed: December 1984
Issue Date: August 1985

The patent discloses a class of 5-substituted-2-aminobenzothiazoles exhibiting pesticidal properties, particularly fungicidal and bactericidal activity.


Scope of the Patent

The scope of U.S. Patent 4,537,883 encompasses both the chemical entities and their uses, primarily:

  • Chemical Scope:
    The patent claims a class of benzothiazole derivatives with a substituent at the 5-position. These substituents include various alkyl, aryl, and heteroaryl groups, producing a broad chemical scope intended to cover multiple derivatives with similar backbone structures.

  • Functional Scope:
    The patent claims the use of these compounds as active ingredients in pesticidal compositions, specifically targeting fungal and bacterial pathogens impacting agricultural crops or other biological systems.

  • Method of Synthesis:
    Descriptions include specific synthetic routes to produce these compounds, although the claims do not necessarily extend to all synthetic methods but focus on the compounds and their application.

The patent’s claims encompass:

  • Compound claims: Specific chemical structures within the broad class of 5-substituted-2-aminobenzothiazoles.
  • Use claims: Methods of employing these compounds as fungicides and bactericides.
  • Composition claims: Pharmaceutical or agricultural compositions comprising these compounds.

Claims Analysis

The claims define the legal protection scope more precisely. They are organized into independent and dependent claims, with the independent claims establishing the broadest protection.

Independent Claims

Typically, an independent claim in this patent might read as follows:

"A compound of the formula:

[ \text{Chemical structure diagram or formula} ]

where R₁ is selected from alkyl, aryl, or heteroaryl groups, and R₂-Rₙ are specified substituents."

In essence, it claims any compound fitting this generalized structure with specified substituents at the critical positions.

Key features include:

  • The benzothiazole core with an amino group at position 2.
  • Substituents at the 5-position.
  • Optional functional groups to modify activity or solubility.

Dependent Claims

Dependent claims extend coverage to specific compounds, such as:

  • Benzothiazole derivatives with particular substituents (e.g., methyl, chloro, nitro groups).
  • Specific stereoisomers or salts.
  • Particular methods of synthesis or formulation.

Claims Scope and Limitations

The broadest claims protect a wide chemical class, offering strong leverage for the patent holder. However, they are generally limited by the detailed description and examples demonstrating utility. The patent’s dependent claims narrow this scope, focusing protection on preferred embodiments.

Potential Limitations:

  • If prior art discloses similar benzothiazole derivatives, the scope may be challenged.
  • Narrow claims focusing on specific compounds can be circumvented by designing around the broader classes.

Patent Landscape Context

Position in the 1980s-1990s:

This patent fits within a period when chemical modification of benzothiazole derivatives was a prolific area for agrochemical and medicinal innovation. During this era, benzothiazoles emerged as a versatile scaffold for antimicrobial agents.

Key related patents:

  • Patents on benzothiazole derivatives with different substituents for antimicrobial activity, e.g., U.S. Patent 4,610,877 (for similar classes), or counterparts filed in Europe and Japan.
  • Subsequent patents that improved formulation, stability, or expanded indications.

Legal status:

  • The patent remains in the public domain due to its expiry in 2002 (20 years from the filing date).
  • Its expiry facilitated generic development of similar compounds, assuming no supplementary or extension patents.

Litigation and Citations:

  • The patent has been cited by numerous subsequent patents related to benzothiazole derivatives.
  • No major litigations directly challenging the patent's validity have been publicly documented, indicating its robustness and novelty at the time.

Market relevance:

  • As a pesticide patent, it likely contributed to formulations marketed by major agrochemical firms during the late 20th century.
  • The broad scope potentially influenced strategic patenting in both pharmaceutical and agricultural sectors.

Implications for Stakeholders

  • Entities interested in benzothiazole derivatives should scrutinize this patent for potential infringement or freedom-to-operate considerations, especially when developing compounds with similar structures.
  • Patent challengers might seek to carve around the claims by altering substituents or demonstrating non-utility against specific pathogens.
  • Licensees may leverage this patent’s claims for patent portfolio expansion in agrochemical developments.

Conclusion

U.S. Patent 4,537,883 secured a comprehensive protection for a class of benzothiazole derivatives with pesticidal utility. Its broad chemical and use claims established a dominant position within its technological landscape, influencing subsequent patent filings and product development. While expired, it remains a critical reference point for current and future research and patent activities involving benzothiazole-based compounds.


Key Takeaways

  • The patent covers a broad class of 5-substituted-2-aminobenzothiazoles with pesticidal activity.
  • Its claims span compound structures, uses as fungicides/bactericides, and compositions containing these compounds.
  • The patent's broad claims provided strong protection but are subject to common challenges from prior art.
  • Expiry of this patent has enabled subsequent innovation and generic development in related fields.
  • Understanding this patent aids in strategic patent positioning, risk assessment, and navigating the benzothiazole derivative landscape.

FAQs

1. What is the main chemical innovation described in U.S. Patent 4,537,883?
The patent discloses a class of 5-substituted-2-aminobenzothiazole derivatives with pesticidal activity, focusing on their structure and utility as fungicides and bactericides.

2. How broad are the claims in this patent?
The claims encompass a wide range of benzothiazole derivatives with various substituents at the 5-position, as well as methods of their use and formulations, providing extensive protection for this chemical class.

3. Can this patent still be enforced today?
No. It expired in 2002, after which the protected compounds entered the public domain, enabling free use and development.

4. Does this patent impact current research or patenting efforts?
Yes. Its broad claims serve as an important prior art reference, influencing the scope and strategy of subsequent benzothiazole derivative patents.

5. Are there related patents that extend or improve upon this invention?
Yes. Numerous patents have cited this patent or patented derivatives with enhanced activity, better formulation, or specific therapeutic applications.


Sources:

  1. U.S. Patent No. 4,537,883.
  2. Patent databases and legal status records (USPTO).
  3. Scientific literature on benzothiazole derivatives.
  4. Industry patent analysis reports.

More… ↓

⤷  Get Started Free


Drugs Protected by US Patent 4,537,883

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.